Market Highlights The Global Myelodysplastic Syndrome (MDS) drugs market is expected to grow significantly over the forecast period. The Myelodysplastic Syndrome (MDS) drugs market held a valuation of USD 1,581.59 million in 2022 and is projected to register a CAGR of 10.1% over the forecast period. The increasing participation of key players is one of the key factors driving the...